1,1,1,2,3,3-HEXAFLUORO-2-IODINE-3-METHOXYPROPANE AS SEMI-PRODUCTS FOR PRODUCTION OF FLUORIDE 2,3,3,3-TETRAFLUORO-2-IODPROPIONYL AND METHOD OF PRODUCING LATTER
Members of P&M-Invest team ,Professor Igumnov Sergey and Boiko Vladimir took part in the conference "Technology and Innovation Industrial Policy Symposium on Advanced Fluorine-Containing Materials in Asian-Pacific Region & The 2nd International Symposium on Collaborative Innovation from Green Fluorine-Chemical Technology", which was held from 16th to 18th of November in Quzhou, China.
The organizer of the conference Professor W. Zhu and a number of leading Chinese scientists presented their reports.
Invited foreign scientists in the field of organofluorine chemistry like Doctor T. Umemoto (Japan), Professor V. Prakash Reddy (USA), Professor N. Shibata (Japan), V. E. Boiko (Russia) also addressed the conference.
Vladimir Boiko made a report on methods of synthesis of trimethylalkylsilanes. During summarizing Professor Sergey Igumnov pointed out that, trifluoromethyl- and perfluoroarylsilanes would soon become relatively cheap, so that it was necessary to develop the methods of their application for introduction of perfluorinated fragments into molecules of organic compounds, which are used not only in pharmaceutics, but also in agrochemistry and special materials.
It took place an unveiling ceremony of Joint Venture "Q&P
Technology Co., Ltd.".
The manufacture of chloropentafluorobenzene, hexafluorobenzene & pentafluorophenol has been started with the total capacity 200 MT per year. We could increase capacity, when it would be required. It is of prime importance that hexachlorobenzene is not used in our manufacture, which one is prohibited under Stockholm Convention.
Our company takes part in the 28th International exhibition of the pharmaceutical industry CPhI Worldwide 2017, which will be held Frankfurt am Main from 24th to 26 th of October. Our colleges can be seen at the booth of Qi-Chem Company as representatives of our Joint venture.
The launch of new production on the basis of the technology developed by P&M-Invest is one of the main activities of our company.Within the framework of an establishment of Joint Venture between the Chinese company Qi-Chem and P&M-Invest at the present time there is Pentafluorophenol's technology development by the representatives of the company Qi-Chem the subsequent production of this product at factory in China. Learning new technologies developed by P&M-Invest is going on at the experimental site near Moscow.
Pentafluorophenol is the main starting material for the production of the drug Sofosbuvir, which is widely used for the treatment of hepatitis C worldwide. Due to the fact that the market consumption of this product is growing rapidly, the need for medical drug is large.
Negotiations, held on February 14-17 between Qi-Chem and P&M-Invest, had resulted in the signing of an agreement to establish a joint venture.
The registration of joint venture is scheduled for April, 2017.
P&M-Invest offers “products from stock” as free samples (not more then 3 substances) in the quantity 5-20g, subject to the publication of their results, obtained based on each sample, in our journal “Fluorine notes” within 6 months. The promotion is valid within 2017.
Note: The delivery of free of samples is paid by receiver.